Barriers to bone marrow transplantation for sickle cell anemia

M. C. Walters, M. Patience, W. Leisenring, J. R. Eckman, G. R. Buchanan, Z. R. Rogers, N. F. Olivieri, E. Vichinsky, S. C. Davies, W. C. Mentzer, D. Powars, J. P. Scott, F. Bernadin, K. Ohene-Frempong, P. J. Darbyshire, A. Wayne, I. A G Roberts, P. Dinndorf, S. Brandalise, J. E. Sanders & 4 others D. C. Matthews, F. R. Appelbaum, R. Storb, K. M. Sullivan

Research output: Contribution to journalArticle

125 Citations (Scopus)

Abstract

While allogeneic marrow transplantation is curative therapy for patients with sickle cell anemia, only a small fraction of patients in the United States receive this treatment. We surveyed participants in our multicenter study of marrow transplantation for sickle cell anemia to determine reasons for not proceeding to transplantation. Among the 4848 patients less than 16 years of age with sickle cell anemia that were followed in 22 collaborating centers, 315 (6.5%) patients were reported to meet protocol entry criteria for transplantation, although there was wide variation among the institutions (0.9-36%). Among the 315 patients eligible for transplantation, 128 (41%) had human leukocyte antigen (HLA) typing performed, and of these 44 (14% of those meeting entry criteria) had an HLA-identical sibling. Common reasons for not proceeding with HLA typing in the remaining 187 patients included lack of a candidate sibling donor (76 patients, 24% of those meeting criteria) and lack of financial or psychosocial support (33, 10.5%). Parental refusal (30, 9.5%), physician refusal (13, 4%), history of medical noncompliance (2, <1%), and other reasons (33, 10.5%) were less frequently cited. To date, 25 patients have been transplanted. Of die remaining 19 patients with HLA-matched donors, seven did not proceed to transplantation because of parental refusal, while the others anticipate a future transplantation (6), have experienced symptomatic improvement (4), or have relocated abroad (2). We conclude that the major barrier to marrow transplantation for sickle cell anemia is lack of an HLA-identical donor. But since only 6.5% of all children with sickle cell disease were considered eligible for transplantation, it is possible that other significant obstacles remain to be identified. For patients reported to meet eligibility criteria, parental refusal and limited financial or psychosocial support were infrequent barriers to transplantation.

Original languageEnglish (US)
Pages (from-to)100-104
Number of pages5
JournalBiology of Blood and Marrow Transplantation
Volume2
Issue number2
StatePublished - May 1996

Fingerprint

Sickle Cell Anemia
Bone Marrow Transplantation
Transplantation
HLA Antigens
Bone Marrow
Tissue Donors
Siblings
Homologous Transplantation
Multicenter Studies
Physicians

Keywords

  • Bone marrow transplantation
  • Multicenter Study
  • Sickle cell anemia

ASJC Scopus subject areas

  • Transplantation

Cite this

Walters, M. C., Patience, M., Leisenring, W., Eckman, J. R., Buchanan, G. R., Rogers, Z. R., ... Sullivan, K. M. (1996). Barriers to bone marrow transplantation for sickle cell anemia. Biology of Blood and Marrow Transplantation, 2(2), 100-104.

Barriers to bone marrow transplantation for sickle cell anemia. / Walters, M. C.; Patience, M.; Leisenring, W.; Eckman, J. R.; Buchanan, G. R.; Rogers, Z. R.; Olivieri, N. F.; Vichinsky, E.; Davies, S. C.; Mentzer, W. C.; Powars, D.; Scott, J. P.; Bernadin, F.; Ohene-Frempong, K.; Darbyshire, P. J.; Wayne, A.; Roberts, I. A G; Dinndorf, P.; Brandalise, S.; Sanders, J. E.; Matthews, D. C.; Appelbaum, F. R.; Storb, R.; Sullivan, K. M.

In: Biology of Blood and Marrow Transplantation, Vol. 2, No. 2, 05.1996, p. 100-104.

Research output: Contribution to journalArticle

Walters, MC, Patience, M, Leisenring, W, Eckman, JR, Buchanan, GR, Rogers, ZR, Olivieri, NF, Vichinsky, E, Davies, SC, Mentzer, WC, Powars, D, Scott, JP, Bernadin, F, Ohene-Frempong, K, Darbyshire, PJ, Wayne, A, Roberts, IAG, Dinndorf, P, Brandalise, S, Sanders, JE, Matthews, DC, Appelbaum, FR, Storb, R & Sullivan, KM 1996, 'Barriers to bone marrow transplantation for sickle cell anemia', Biology of Blood and Marrow Transplantation, vol. 2, no. 2, pp. 100-104.
Walters, M. C. ; Patience, M. ; Leisenring, W. ; Eckman, J. R. ; Buchanan, G. R. ; Rogers, Z. R. ; Olivieri, N. F. ; Vichinsky, E. ; Davies, S. C. ; Mentzer, W. C. ; Powars, D. ; Scott, J. P. ; Bernadin, F. ; Ohene-Frempong, K. ; Darbyshire, P. J. ; Wayne, A. ; Roberts, I. A G ; Dinndorf, P. ; Brandalise, S. ; Sanders, J. E. ; Matthews, D. C. ; Appelbaum, F. R. ; Storb, R. ; Sullivan, K. M. / Barriers to bone marrow transplantation for sickle cell anemia. In: Biology of Blood and Marrow Transplantation. 1996 ; Vol. 2, No. 2. pp. 100-104.
@article{e53f5d830a9d4575be64bcc6e66b7dc9,
title = "Barriers to bone marrow transplantation for sickle cell anemia",
abstract = "While allogeneic marrow transplantation is curative therapy for patients with sickle cell anemia, only a small fraction of patients in the United States receive this treatment. We surveyed participants in our multicenter study of marrow transplantation for sickle cell anemia to determine reasons for not proceeding to transplantation. Among the 4848 patients less than 16 years of age with sickle cell anemia that were followed in 22 collaborating centers, 315 (6.5{\%}) patients were reported to meet protocol entry criteria for transplantation, although there was wide variation among the institutions (0.9-36{\%}). Among the 315 patients eligible for transplantation, 128 (41{\%}) had human leukocyte antigen (HLA) typing performed, and of these 44 (14{\%} of those meeting entry criteria) had an HLA-identical sibling. Common reasons for not proceeding with HLA typing in the remaining 187 patients included lack of a candidate sibling donor (76 patients, 24{\%} of those meeting criteria) and lack of financial or psychosocial support (33, 10.5{\%}). Parental refusal (30, 9.5{\%}), physician refusal (13, 4{\%}), history of medical noncompliance (2, <1{\%}), and other reasons (33, 10.5{\%}) were less frequently cited. To date, 25 patients have been transplanted. Of die remaining 19 patients with HLA-matched donors, seven did not proceed to transplantation because of parental refusal, while the others anticipate a future transplantation (6), have experienced symptomatic improvement (4), or have relocated abroad (2). We conclude that the major barrier to marrow transplantation for sickle cell anemia is lack of an HLA-identical donor. But since only 6.5{\%} of all children with sickle cell disease were considered eligible for transplantation, it is possible that other significant obstacles remain to be identified. For patients reported to meet eligibility criteria, parental refusal and limited financial or psychosocial support were infrequent barriers to transplantation.",
keywords = "Bone marrow transplantation, Multicenter Study, Sickle cell anemia",
author = "Walters, {M. C.} and M. Patience and W. Leisenring and Eckman, {J. R.} and Buchanan, {G. R.} and Rogers, {Z. R.} and Olivieri, {N. F.} and E. Vichinsky and Davies, {S. C.} and Mentzer, {W. C.} and D. Powars and Scott, {J. P.} and F. Bernadin and K. Ohene-Frempong and Darbyshire, {P. J.} and A. Wayne and Roberts, {I. A G} and P. Dinndorf and S. Brandalise and Sanders, {J. E.} and Matthews, {D. C.} and Appelbaum, {F. R.} and R. Storb and Sullivan, {K. M.}",
year = "1996",
month = "5",
language = "English (US)",
volume = "2",
pages = "100--104",
journal = "Biology of Blood and Marrow Transplantation",
issn = "1083-8791",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Barriers to bone marrow transplantation for sickle cell anemia

AU - Walters, M. C.

AU - Patience, M.

AU - Leisenring, W.

AU - Eckman, J. R.

AU - Buchanan, G. R.

AU - Rogers, Z. R.

AU - Olivieri, N. F.

AU - Vichinsky, E.

AU - Davies, S. C.

AU - Mentzer, W. C.

AU - Powars, D.

AU - Scott, J. P.

AU - Bernadin, F.

AU - Ohene-Frempong, K.

AU - Darbyshire, P. J.

AU - Wayne, A.

AU - Roberts, I. A G

AU - Dinndorf, P.

AU - Brandalise, S.

AU - Sanders, J. E.

AU - Matthews, D. C.

AU - Appelbaum, F. R.

AU - Storb, R.

AU - Sullivan, K. M.

PY - 1996/5

Y1 - 1996/5

N2 - While allogeneic marrow transplantation is curative therapy for patients with sickle cell anemia, only a small fraction of patients in the United States receive this treatment. We surveyed participants in our multicenter study of marrow transplantation for sickle cell anemia to determine reasons for not proceeding to transplantation. Among the 4848 patients less than 16 years of age with sickle cell anemia that were followed in 22 collaborating centers, 315 (6.5%) patients were reported to meet protocol entry criteria for transplantation, although there was wide variation among the institutions (0.9-36%). Among the 315 patients eligible for transplantation, 128 (41%) had human leukocyte antigen (HLA) typing performed, and of these 44 (14% of those meeting entry criteria) had an HLA-identical sibling. Common reasons for not proceeding with HLA typing in the remaining 187 patients included lack of a candidate sibling donor (76 patients, 24% of those meeting criteria) and lack of financial or psychosocial support (33, 10.5%). Parental refusal (30, 9.5%), physician refusal (13, 4%), history of medical noncompliance (2, <1%), and other reasons (33, 10.5%) were less frequently cited. To date, 25 patients have been transplanted. Of die remaining 19 patients with HLA-matched donors, seven did not proceed to transplantation because of parental refusal, while the others anticipate a future transplantation (6), have experienced symptomatic improvement (4), or have relocated abroad (2). We conclude that the major barrier to marrow transplantation for sickle cell anemia is lack of an HLA-identical donor. But since only 6.5% of all children with sickle cell disease were considered eligible for transplantation, it is possible that other significant obstacles remain to be identified. For patients reported to meet eligibility criteria, parental refusal and limited financial or psychosocial support were infrequent barriers to transplantation.

AB - While allogeneic marrow transplantation is curative therapy for patients with sickle cell anemia, only a small fraction of patients in the United States receive this treatment. We surveyed participants in our multicenter study of marrow transplantation for sickle cell anemia to determine reasons for not proceeding to transplantation. Among the 4848 patients less than 16 years of age with sickle cell anemia that were followed in 22 collaborating centers, 315 (6.5%) patients were reported to meet protocol entry criteria for transplantation, although there was wide variation among the institutions (0.9-36%). Among the 315 patients eligible for transplantation, 128 (41%) had human leukocyte antigen (HLA) typing performed, and of these 44 (14% of those meeting entry criteria) had an HLA-identical sibling. Common reasons for not proceeding with HLA typing in the remaining 187 patients included lack of a candidate sibling donor (76 patients, 24% of those meeting criteria) and lack of financial or psychosocial support (33, 10.5%). Parental refusal (30, 9.5%), physician refusal (13, 4%), history of medical noncompliance (2, <1%), and other reasons (33, 10.5%) were less frequently cited. To date, 25 patients have been transplanted. Of die remaining 19 patients with HLA-matched donors, seven did not proceed to transplantation because of parental refusal, while the others anticipate a future transplantation (6), have experienced symptomatic improvement (4), or have relocated abroad (2). We conclude that the major barrier to marrow transplantation for sickle cell anemia is lack of an HLA-identical donor. But since only 6.5% of all children with sickle cell disease were considered eligible for transplantation, it is possible that other significant obstacles remain to be identified. For patients reported to meet eligibility criteria, parental refusal and limited financial or psychosocial support were infrequent barriers to transplantation.

KW - Bone marrow transplantation

KW - Multicenter Study

KW - Sickle cell anemia

UR - http://www.scopus.com/inward/record.url?scp=0030133622&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030133622&partnerID=8YFLogxK

M3 - Article

VL - 2

SP - 100

EP - 104

JO - Biology of Blood and Marrow Transplantation

JF - Biology of Blood and Marrow Transplantation

SN - 1083-8791

IS - 2

ER -